Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
This is a Phase 2 clinical trial update reporting results for melphalan, lenalidomide, and dexamethasone in AL amyloidosis (primary systemic…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 trial comparing lenalidomide plus low-dose dexamethasone with continuous oral cyclophosphamide versus lenalidomide/dex…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib [Phase 3]
A Phase 3 trial evaluating optimized retreatment and prolonged therapy with bortezomib in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma [Phase 1]
Phase 1 trial evaluating lenalidomide after donor stem cell transplant with bortezomib in high-risk multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating LDE225 (sonidegib) in combination with bortezomib for relapsed or relapsed/refractory multiple myeloma was terminat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 3]
This is a Phase 3 trial comparing daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refra…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma [Phase 3]
A phase 3 trial assessed adding daratumumab to bortezomib and dexamethasone in relapsed or refractory multiple myeloma; results from the stu…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]
Phase 2 trial evaluating epoetin alfa or darbepoetin alfa for chemotherapy-induced anemia; results from a completed study were posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update covers a phase 1/2 study evaluating haploidentical bone marrow stem cell transplantation in patients with multipl…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Velcade (Bortezomib) Consolidation After Transplant [Phase 3]
Phase 3 trial evaluating Velcade (bortezomib) as consolidation after transplant in multiple myeloma. The study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome [NA]
This clinical trial update indicates the Lactobacillus probiotic study intended to prevent infection in patients undergoing donor stem cell …
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD [Phase 2]
A Phase 2 clinical trial evaluating daratumumab in adults with multiple myeloma who had at least 3 prior therapies or were refractory to a P…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis [Phase 2]
Phase 2 trial update evaluating a second autologous stem cell transplant in patients with persistent or recurrent AL amyloidosis, with resul…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone [Phase 2]
This Phase 2 trial in patients aged 65 and older with newly diagnosed multiple myeloma compared two frontline regimens: sequential melphalan…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. [NA]
A completed clinical trial assessing the impact of varying DMSO concentrations on hematopoietic recovery after autologous hematopoietic stem…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating pazopanib (GW786034) in subjects with relapsed or refractory multiple myeloma has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens [Phase 2]
Phase 2 study evaluating subcutaneous bortezomib regimens in relapsed/refractory multiple myeloma after prior IV bortezomib; the trial was t…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating post-transplant autologous cytokine-induced killer (CIK) cells in high-risk hematologic malignancies has been compl…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma [EARLY_Phase 1]
A completed early-phase 1 safety study evaluating the combination of Velcade (bortezomib) and G-CSF in patients with multiple myeloma or mal…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients [Phase 2]
Phase 2 trial assessing safety of elotuzumab given over ~60 minutes with lenalidomide and dexamethasone in newly diagnosed or relapsed/refra…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase III trial of lenalidomide and dexamethasone with or without elotuzumab in relapsed or refractory multiple myeloma completed; results p…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating MAGE-A3 protein plus AS15 as consolidation therapy after autologous stem cell transplantation in multiple myeloma p…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
A completed clinical trial assessing and comparing costs of two mobilization strategies for patients with multiple myeloma undergoing blood …
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients [NA]
This clinical trial compares microtransplantation to autologous stem cell transplantation in patients with relapsed multiple myeloma; curren…